Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Everolimus.

Menu
$ API Ref.Price (USD/KG) : 263,673Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Gowling Lafleur Henderson LLP

02 17Gowling Lafleur Henderson LLP

03 25Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2145383

Filing Date : 1993-09-24

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-24

Date Granted : 2004-11-16

blank

02

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2351580

Filing Date : 1999-12-06

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-06

Date Granted : 2012-03-20

blank

03

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2145383

Filing Date : 1993-09-24

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-24

Date Granted : 2004-11-16

blank

04

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2225960

Filing Date : 1996-07-12

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-07-12

Date Granted : 2004-05-11

blank

05

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2351580

Filing Date : 1999-12-06

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-06

Date Granted : 2012-03-20

blank

06

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2145383

Filing Date : 1993-09-24

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-09-24

Date Granted : 2004-11-16

blank

07

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2225960

Filing Date : 1996-07-12

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-07-12

Date Granted : 2004-05-11

blank

08

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : AFINITOR

Patent Number : 2351580

Filing Date : 1999-12-06

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-06

Date Granted : 2012-03-20

blank

09

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : CERTICAN

Patent Number : 2351580

Filing Date : 1999-12-06

Strength per Unit : 0.25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-06

Date Granted : 2012-03-20

blank

10

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Everolimus

Brand Name : CERTICAN

Patent Number : 2351580

Filing Date : 1999-12-06

Strength per Unit : 0.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-06

Date Granted : 2012-03-20

blank